Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

ViroXis (San Antonio, TX) a development stage biopharmaceutical company focused on antiviral treatment of HPV associated skin warts, closed a $2.5M Series A financing. Participants include Texas Emerging Technology Fund.

Prolong Pharmaceuticals (South Plainfield, NJ) a near clinical-stage biopharmaceuticals company focused sickle cell anemia, stroke and diabetic induced ischemia, closed a $30M Series C financing. Participants were not identified.

Noxxon Pharma (Germany) a clinical-stage biopharmaceutical company focused on the development of aptamers for the treatment of inflammation and hematological indications closed a $2.6M Series D financing, bringing the total round to $42.6M. Participants include NGN Capital, TVM Capital, Sofinnova Partners, Edmond de Rothschild Investment Partners, Seventure Partners, VC Fonds Technologie Berlin, Dow Venture Capital, […]

NanoInk (Skokie, IL) a commercial-stage a protein analysis, biomaterial manufacturing and biodiscovery assay kit developer, closed a$65M Series E financing. Participants include Lurie Investment Fund.

Acylin Therapeutics (Seattle, WA) a development-stage biopharma company focused on inhibiting histone acetyltransferase in cancer, metabolic disease, and neurodegeneration indications, closed a $4.4M Series F financing. Participants include Alexandria Real Estate Equities, Amgen Ventures, ARCH Venture Partners, OVP Venture Partners, PPD and Washington Research Foundation Capital.

Ocimum Biosolutions (Gaithersburg, MD) a commercial-stage integrated genomics company focused on sample data analysis and management, closed a $8M Series C financing. Participants have included International Finance Corp. and Kubera Partners.

Hutchison MediPharma (China) a clinical-stage biopharmaceutical company focused on inflammatory bowel disease and oncology, closed a $12.5M Series B financing. Participants include SB China Venture Capital and Mitsui & Co.

NeoGraft Technologies (Pittsburgh, PA) a development-stage medical device company focused on coronary artery disease, closed a $3M Series B financing. Participants were not identified.

Small Bone Innovations (Morrisville, PA) a commercial-stage a small bone and joint device company focused on arthroplasty, fixation, trauma and biologic solutions, closed a $15M Series F financing. Participants have included 3i Group, NGN Capital, Trevi Health Ventures, Viscogliosi Brothers, Vollin Holdings and The Family Office Co.

23andMe (Mountain View, CA) a commercial-stage personalized genomics company focused on aiding individuals with DNA analysis technologies and web-based interactive tools, closed a $22M Series C financing. Participants include Johnson & Johnson Development Corp, New Enterprise Associates, Google Ventures and MPM Capital.

Symetis (Switzerland) a clinical-stage medical device company focused on a transcatheter aortic valve implantation, closed a $25.8M Series C financing. Participants include Endeavour Vision, NBGI Ventures, Truffle Capital, Novartis Venture Fund, Wellington Partners Venture Capital, Vinci Capital, Renaissance PME, Banexi Venture Partners and BiomedInvest.

WebPT (Phoenix, AZ) a commercial-stage web-based electronic medical records systems for physical therapists, closed a $1M Series A financing. Participants include Canal Partners.

DICOM Grid (Phoenix, AZ) a development-stage bioinformatics company focused on the development of medical imaging software, closed a $7.5M Series A financing. Participants include Canaan Partners and CHL Medical Partners.

« Previous Entries  Next Page »

to top of page...